NCT07226479

Brief Summary

The non-invasive central venous pressure estimation in adult cardiac intensive care units (CICU) patients study is a single-center, single-arm, investigator-blinded, interventional, intra-participant comparative, feasibility study. This study aims to assess the safety and preliminary accuracy of external jugular venous occlusion pressure measured non-invasively with the venous occlusion pressure monitoring device (CPMX2) in adult CICU patients. As a feasibility study, the primary goal is to gather preliminary data on the feasibility, safety, and effectiveness of the non-invasive CVP estimation method. Although single arm, the study will compare non-invasive CVP measurements with standard invasive CVP measurements taken concurrently. This intra-participant comparative approach is essential to validate the correlation and reliability of the non-invasive method.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jan 2026Nov 2026

First Submitted

Initial submission to the registry

November 6, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 10, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

January 6, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

10 months

First QC Date

November 6, 2025

Last Update Submit

January 16, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mean venous pressure to assess accuracy

    Mean CPMX2 external jugular occlusion pressure will be compared to invasive CVP measurement in mmHg

    Day 1

  • Number of adverse events to assess safety

    Safety measured by number of adverse events related to or potentially related to the study device and device deficiencies reported during study

    Day 1

  • Number of device deficiencies to assess safety

    Safety measured by number of device deficiencies reported during study

    Day 1

Secondary Outcomes (1)

  • Mean Point-of-care ultrasound (POCUS)-derived pressure measurements

    Day 1

Study Arms (1)

Adult CICU patients- CPMX2

EXPERIMENTAL

Adult participants admitted to the CICU will have external jugular venous occlusion pressure measured twice non-invasively with the venous occlusion pressure monitoring device (CPMX2) and twice using standard of care invasive central venous pressure (CVP) measurements. All measurements will be taken concurrently. This is a with-in participant design.

Device: CPMX2

Interventions

CPMX2DEVICE

Non-invasive venous occlusion pressure monitoring device

Adult CICU patients- CPMX2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent
  • Admitted to the CICU with invasive CVP/RA pressure monitoring placed by standard of care as determined by the treating team before enrollment
  • No more than moderate TR as assessed by echocardiogram

You may not qualify if:

  • Undergoing positive pressure ventilation (Bipap or invasive mechanical ventilation)
  • Non-visible external jugular vein bilaterally (by visual examination or with traditional ultrasound examination)
  • History of thrombosis in any of the following vessels bilaterally; external jugular vein, internal jugular vein, brachiocephalic vein or superior vena cava
  • Skin lesions, vascular access sites or dressings covering neck and impeding access to the external jugular veins at the level of the muscle belly of the sternocleidomastoid muscle

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale New Haven Hospital CICU

New Haven, Connecticut, 06520, United States

RECRUITING

Study Officials

  • Elliott Miller, MD, MHS

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elliott Miller, MD, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Adult patients admitted to the CICU with invasive CVP/RA pressure measurements (Central line or pulmonary artery catheter) placed by standard of care as determined by the treating team before enrollment. With-in participant design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2025

First Posted

November 10, 2025

Study Start

January 6, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations